Academic literature on the topic 'Tyrosinase inhibitors'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Tyrosinase inhibitors.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Tyrosinase inhibitors"

1

Kurihara, Hideyuki, and Kazuki Kujira. "Phlorotannins Derived From the Brown Alga Colpomenia bullosa as Tyrosinase Inhibitors." Natural Product Communications 16, no. 7 (2021): 1934578X2110213. http://dx.doi.org/10.1177/1934578x211021317.

Full text
Abstract:
Tyrosinase catalyzes hydroxylation of L-tyrosine and dehydrogenation of L-DOPA in the melanin biosynthesis pathway. Tyrosinase inhibitors have potential use as cosmetic whitening agents and for preventing seafood deterioration. In this report, tyrosinase inhibitors extracted from brown alga Colpomenia bullosa (Scytosiphonaceae, Scytosiphonales) were investigated. Inhibitory principles were isolated from the extract and identified as phlorotannins, phloroglucinol (1), diphlorethol (2), triphlorethol C (3), which have not been isolated in a free form previously, and fucophlorethol C (4). Compoun
APA, Harvard, Vancouver, ISO, and other styles
2

Li, Qi, Hongyu Yang, Jun Mo, et al. "Identification by shape-based virtual screening and evaluation of new tyrosinase inhibitors." PeerJ 6 (January 26, 2018): e4206. http://dx.doi.org/10.7717/peerj.4206.

Full text
Abstract:
Targeting tyrosinase is considered to be an effective way to control the production of melanin. Tyrosinase inhibitor is anticipated to provide new therapy to prevent skin pigmentation, melanoma and neurodegenerative diseases. Herein, we report our results in identifying new tyrosinase inhibitors. The shape-based virtual screening was performed to discover new tyrosinase inhibitors. Thirteen potential hits derived from virtual screening were tested by biological determinations. Compound 5186-0429 exhibited the most potent inhibitory activity. It dose-dependently inhibited the activity of tyrosi
APA, Harvard, Vancouver, ISO, and other styles
3

Kim, Chang, Sang Noh, Yujin Park та ін. "A Potent Tyrosinase Inhibitor, (E)-3-(2,4-Dihydroxyphenyl)-1-(thiophen-2-yl)prop-2-en-1-one, with Anti-Melanogenesis Properties in α-MSH and IBMX-Induced B16F10 Melanoma Cells". Molecules 23, № 10 (2018): 2725. http://dx.doi.org/10.3390/molecules23102725.

Full text
Abstract:
In this study, we designed and synthesized eight thiophene chalcone derivatives (1a–h) as tyrosinase inhibitors and evaluated their mushroom tyrosinase inhibitory activities. Of these eight compounds, (E)-3-(2,4-dihydroxyphenyl)-1-(thiophen-2-yl)prop-2-en-1-one (1c) showed strong competitive inhibition activity against mushroom tyrosinase with IC50 values of 0.013 μM for tyrosine hydroxylase and 0.93 μM for dopa oxidase. In addition, we used enzyme kinetics study and docking program to further evaluate the inhibitory mechanism of 1c toward tyrosinase. As an underlying mechanism of 1c mediated
APA, Harvard, Vancouver, ISO, and other styles
4

Choi, Joonhyeok, Trilok Neupane, Rishiram Baral, and Jun-Goo Jee. "Hydroxamic Acid as a Potent Metal-Binding Group for Inhibiting Tyrosinase." Antioxidants 11, no. 2 (2022): 280. http://dx.doi.org/10.3390/antiox11020280.

Full text
Abstract:
Tyrosinase, a metalloenzyme containing a dicopper cofactor, plays a central role in synthesizing melanin from tyrosine. Many studies have aimed to identify small-molecule inhibitors of tyrosinase for pharmaceutical, cosmetic, and agricultural purposes. In this study, we report that hydroxamic acid is a potent metal-binding group for interacting with dicopper atoms, thereby inhibiting tyrosinase. Hydroxamate-containing molecules, including anticancer drugs targeting histone deacetylase, vorinostat and panobinostat, significantly inhibited mushroom tyrosinase, with inhibitory constants in the su
APA, Harvard, Vancouver, ISO, and other styles
5

Micillo, Raffaella, Julia Sirés-Campos, José García-Borrón, Lucia Panzella, Alessandra Napolitano, and Conchi Olivares. "Conjugation with Dihydrolipoic Acid Imparts Caffeic Acid Ester Potent Inhibitory Effect on Dopa Oxidase Activity of Human Tyrosinase." International Journal of Molecular Sciences 19, no. 8 (2018): 2156. http://dx.doi.org/10.3390/ijms19082156.

Full text
Abstract:
Caffeic acid derivatives represent promising lead compounds in the search for tyrosinase inhibitors to be used in the treatment of skin local hyperpigmentation associated to an overproduction or accumulation of melanin. We recently reported the marked inhibitory activity of a conjugate of caffeic acid with dihydrolipoic acid, 2-S-lipoylcaffeic acid (LCA), on the tyrosine hydroxylase (TH) and dopa oxidase (DO) activities of mushroom tyrosinase. In the present study, we evaluated a more lipophilic derivative, 2-S-lipoyl caffeic acid methyl ester (LCAME), as an inhibitor of tyrosinase from human
APA, Harvard, Vancouver, ISO, and other styles
6

Honisch, Claudia, Matteo Gazziero, Roberto Dallocchio, et al. "Antamanide Analogs as Potential Inhibitors of Tyrosinase." International Journal of Molecular Sciences 23, no. 11 (2022): 6240. http://dx.doi.org/10.3390/ijms23116240.

Full text
Abstract:
The tyrosinase enzyme, which catalyzes the hydroxylation of monophenols and the oxidation of o-diphenols, is typically involved in the synthesis of the dark product melanin starting from the amino acid tyrosine. Contributing to the browning of plant and fruit tissues and to the hyperpigmentation of the skin, leading to melasma or age spots, the research of possible tyrosinase inhibitors has attracted much interest in agri-food, cosmetic, and medicinal industries. In this study, we analyzed the capability of antamanide, a mushroom bioactive cyclic decapeptide, and some of its glycine derivative
APA, Harvard, Vancouver, ISO, and other styles
7

Abuelizz, Hatem A., El Hassane Anouar, Mohamed Marzouk, et al. "Evaluation of Cytotoxic and Tyrosinase Inhibitory Activities of 2-phenoxy(thiomethyl) pyridotriazolopyrimidines: In Vitro and Molecular Docking Studies." Anti-Cancer Agents in Medicinal Chemistry 20, no. 14 (2020): 1714–21. http://dx.doi.org/10.2174/1871520620666200627212128.

Full text
Abstract:
Background: The use of tyrosinase has confirmed to be the best means of recognizing safe, effective, and potent tyrosinase inhibitors for whitening skin. Twenty-four 2-phenoxy(thiomethyl)pyridotriazolopyrimidines were synthesized and characterized in our previous studies. Objective: The present work aimed to evaluate their cytotoxicity against HepG2 (hepatocellular carcinoma), A549 (pulmonary adenocarcinoma), MCF-7 (breast adenocarcinoma) and WRL 68 (embryonic liver) cell lines. Methods: MTT assay was employed to investigate the cytotoxicity, and a tyrosinase inhibitor screening kit was used t
APA, Harvard, Vancouver, ISO, and other styles
8

Lee, Sanggwon, Heejeong Choi, Yujin Park, et al. "Urolithin and Reduced Urolithin Derivatives as Potent Inhibitors of Tyrosinase and Melanogenesis: Importance of the 4-Substituted Resorcinol Moiety." International Journal of Molecular Sciences 22, no. 11 (2021): 5616. http://dx.doi.org/10.3390/ijms22115616.

Full text
Abstract:
We previously reported (E)-β-phenyl-α,β-unsaturated carbonyl scaffold ((E)-PUSC) played an important role in showing high tyrosinase inhibitory activity and that derivatives with a 4-substituted resorcinol moiety as the β-phenyl group of the scaffold resulted in the greatest tyrosinase inhibitory activity. To examine whether the 4-substituted resorcinol moiety could impart tyrosinase inhibitory activity in the absence of the α,β-unsaturated carbonyl moiety of the (E)-PUSC scaffold, 10 urolithin derivatives were synthesized. To obtain more candidate samples, the lactone ring in synthesized urol
APA, Harvard, Vancouver, ISO, and other styles
9

Parveen, Naima, Sharique Akhtar Ali, and Ayesha Sharique Ali. "Insights Into the Explication of Potent Tyrosinase Inhibitors with Reference to Computational Studies." Letters in Drug Design & Discovery 16, no. 11 (2019): 1182–93. http://dx.doi.org/10.2174/1570180815666180803111021.

Full text
Abstract:
Background: Pigment melanin has primarily a photo defensive role in human skin, its unnecessary production and irregular distribution can cause uneven skin tone ultimately results in hyper pigmentation. Melanin biosynthesis is initiated by tyrosine oxidation through tyrosinase, the key enzyme for melanogenesis. Not only in humans, tyrosinase is also widely distributed in plants and liable for browning of vegetables and fruits. Search for the inhibitors of tyrosinase have been an important target to facilitate development of therapies for the prevention of hyperpigmentary disorders and an undes
APA, Harvard, Vancouver, ISO, and other styles
10

Pintus, Francesca, Delia Spanò, Angela Corona, and Rosaria Medda. "Antityrosinase activity ofEuphorbia characiasextracts." PeerJ 3 (October 13, 2015): e1305. http://dx.doi.org/10.7717/peerj.1305.

Full text
Abstract:
Tyrosinase is a well-known key enzyme in melanin biosynthesis and its inhibitors have become increasingly important because of their potential use as hypopigmenting agents. In the present study, the anti-melanogenic effect of aqueous and ethanolic extracts fromEuphorbia characiasleaves, stems, and flowers in cell-free and cellular systems was examined. All the extracts showed inhibitory effects against mushroom tyrosinase with leaf extracts exhibiting the lowest IC50values of 24 and 97 µg/mL for aqueous and ethanolic extracts respectively. Enzyme kinetic analysis indicated that leaf aqueous ex
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Tyrosinase inhibitors"

1

Yeap, S. K. "The design of tyrosinase inhibitors as novel chemotherapeutic agents." Thesis, University of Sunderland, 1987. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.378608.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Zheng, Zongping, and 郑宗平. "Isolation and structural elucidation of tyrosinase inhibitors from five plant extracts." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2011. http://hub.hku.hk/bib/B45700072.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Narli, Isil. "Activity Analysis Of Immobilized Tyrosinase In The Presence Of Different Inhibitors." Master's thesis, METU, 2006. http://etd.lib.metu.edu.tr/upload/2/12607238/index.pdf.

Full text
Abstract:
ACTIVITY ANALYSIS OF IMMOBILIZED TYROSINASE ENZYME IN THE PRESENCE OF DIFFERENT INHIBITORS Narli, ISil M.Sc., Department of Chemistry Supervisor: Prof. Dr. Levent Toppare May 2006, 97 pages Immobilization of tyrosinase enzyme was performed in the matrices obtained via copolymerization of terephthalic acid bis-(2-thiophen-3-yl ethyl) ester (TATE) with pyrrole. During electrochemical polymerization of pyrrole, enzyme molecules were entrapped in the copolymer matrice. Activity measurements were performed by using Besthorn&amp<br>#8217<br>s Hydrazone method which includes spectrophotometri
APA, Harvard, Vancouver, ISO, and other styles
4

Nicoll, Kathryn. "Synthesis of specific inhibitors of phosphoenolpyruvate carboxylase and substrates for tyrosinase." Thesis, University of Glasgow, 2006. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.438920.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Shi, Gengxuan. "Tyrosinase Inhibitors from Traditional Chinese Medicine as Potential Anti-hyperpigmentation agents." Thesis, Griffith University, 2019. http://hdl.handle.net/10072/387690.

Full text
Abstract:
Several treatments for skin pigmentation are available today, however, many have unwanted side effects. Classic drugs like hydroquinone, arbutin, mequinol and kojic acid have been considered strongly carcinogenic, with related adverse effects. Traditional Chinese medicines (TCMs) have long been documented for their skin-lightening properties with little known negative effects. However, little is known about precisely how these herbal medicines work and what are the chemical basis for their activity. In this project, a 96-well plate based tyrosinase assay was established and used to test 44 TCM
APA, Harvard, Vancouver, ISO, and other styles
6

Hossain, Abzal. "Inhibition of tyrosinase activity by metallothionein from Aspergillus niger." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1999. http://www.collectionscanada.ca/obj/s4/f2/dsk1/tape7/PQDD_0015/MQ55068.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Ronauld, Ninon Geornest Eudes. "Detection of selective Tyrosinase inhibitors from some South African plant extracts of Lamiaceae family." University of the Western Cape, 2016. http://hdl.handle.net/11394/5721.

Full text
Abstract:
Magister Scientiae - MSc (Chemistry)<br>Various dermatological disorders, such as formation of black pigmented patches on the surface of the skin arise from the over-activity of tyrosinase enzyme's degenerative action. This enzyme is further implicated in the involvement of melanin in malignant melanoma, the most lifethreatening skin tumors. Although, synthetic products were found effective to combat this menace, nevertheless, overtime detrimental effect on human skin is a challenge. Investigation of natural tyrosinase inhibitors from methanol extracts of medicinal plants of Lamiaceae fam
APA, Harvard, Vancouver, ISO, and other styles
8

Etsassala, Ninon Geornest Eudes Ronauld. "Detection of selective tyrosinase inhibitors from some South African plant extracts of lamiaceae family." University of the Western Cape, 2016. http://hdl.handle.net/11394/5439.

Full text
Abstract:
Magister Scientiae - MSc<br>Various dermatological disorders, such as formation of black pigmented patches on the surface of the skin arise from the over-activity of tyrosinase enzyme's degenerative action. This enzyme is further implicated in the involvement of melanin in malignant melanoma, the most lifethreatening skin tumors. Although, synthetic products were found effective to combat this menace, nevertheless, overtime detrimental effect on human skin is a challenge. Investigation of natural tyrosinase inhibitors from methanol extracts of medicinal plants of Lamiaceae family using L-tyros
APA, Harvard, Vancouver, ISO, and other styles
9

Streffer, Katrin. "Highly sensitive measurements of substrates and inhibitors on the basis of tyrosinase sensors and recycling systems." Phd thesis, [S.l. : s.n.], 2002. http://pub.ub.uni-potsdam.de/2003/0001/streffer.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Madani, Wigdan. "Characterization of a polyphenol esterase from Aspergillus niger and its role in the inhibition of tyrosinase." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 2000. http://www.collectionscanada.ca/obj/s4/f2/dsk1/tape2/PQDD_0035/NQ64612.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Tyrosinase inhibitors"

1

Focosi, Daniele, ed. Resistance to Tyrosine Kinase Inhibitors. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-46091-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Cunningham, Bernadette Deirdre Mary. Flavones and related compounds as inhibitors of protein tyrosine kinases. Aston University. Department of Pharmaceutical Sciences, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Kotoris, Christopher C. Studies on intramolecular peptide bond cleavage and design and synthesis of protein tyrosine phosphatase inhibitors. National Library of Canada, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Tsiani, Evangelia. Regulation of metabolic effects in L6 muscle cells by sulfonylureas and the protein tyrosine phosphatase inhibitors vanadate and pervanadate. National Library of Canada = Bibliothèque nationale du Canada, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Matthews, David J. Targeting protein kinases for cancer therapy. John Wiley & Sons, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

E, Gerritsen Mary, ed. Targeting protein kinases for cancer therapy. John Wiley & Sons, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Rommel, Christian. Phosphoinositide 3-kinase in Health and Disease: Volume 2. Springer-Verlag Berlin Heidelberg, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Phosphoinositide 3-kinase in health and disease. Springer Verlag, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Focosi, Daniele. Resistance to Tyrosine Kinase Inhibitors. Springer International Publishing AG, 2018.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Focosi, Daniele. Resistance to Tyrosine Kinase Inhibitors. Springer, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Tyrosinase inhibitors"

1

Srivastava, Jyoti, Joyabrata Mal, Manju Verma, and Rupika Sinha. "Mini-review on Inhibitors of Human Tyrosinase." In Proceedings of the Conference BioSangam 2022: Emerging Trends in Biotechnology (BIOSANGAM 2022). Atlantis Press International BV, 2022. http://dx.doi.org/10.2991/978-94-6463-020-6_10.

Full text
Abstract:
AbstractMelanin is a major pigment of human skin that protects the skin from harmful ultraviolet radiation, DNA damage and oxidative stress. However, the excess accumulation of melanin may lead to various hyperpigmentation-related diseases. Tyrosinase is a copper containing enzyme that regulates the rate-limiting step of melanin synthesis. So, inhibiting tyrosinase is the crucial target for researchers for the treatment of hyperpigmentation. Unfortunately, almost all the literature is based on mushroom tyrosinase (mTYR) for their application on humans as pure human tyrosinase (hTYR) is difficult to isolate. Since presently used tyrosinase inhibitors are developed using mushroom tyrosinase, they are insufficient to match the affinity, selectivity and efficacy required to target the human tyrosinase. Therefore, there is an urgent need for identifying a selective tyrosinase inhibitor that matches the selectivity and safety standards of human tyrosinase. This mini-review is focused on the tyrosinase inhibitors developed and evaluated using human tyrosinase.
APA, Harvard, Vancouver, ISO, and other styles
2

Kubo, Isao. "Tyrosinase Inhibitors from Plants." In Phytochemicals for Pest Control. American Chemical Society, 1997. http://dx.doi.org/10.1021/bk-1997-0658.ch024.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

García-Echeverría, Carlos. "Inhibitors of Signaling Interfaces." In Protein Tyrosine Kinases. Humana Press, 2006. http://dx.doi.org/10.1385/1-59259-962-1:031.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Cakar, Burcu, and Erdem Göker. "Tyrosine Kinase Inhibitors." In Breast Disease. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-26012-9_36.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Cakar, Burcu, and Erdem Göker. "Tyrosine Kinase Inhibitors." In Breast Disease. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-16792-9_35.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Duhé, Roy J. "Tyrosine Kinase Inhibitors." In Encyclopedia of Cancer. Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-642-27841-9_6080-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Abad, Cybele Lara R., and Raymund R. Razonable. "Tyrosine-Kinase Inhibitors." In Infectious Complications in Biologic and Targeted Therapies. Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-031-11363-5_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Duhé, Roy J. "Tyrosine Kinase Inhibitors." In Encyclopedia of Cancer. Springer Berlin Heidelberg, 2017. http://dx.doi.org/10.1007/978-3-662-46875-3_6080.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Duhé, Roy J. "Tyrosine Kinase Inhibitors." In Encyclopedia of Cancer. Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-16483-5_6080.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Moses, Marsha A. "Tyrosine Kinase Inhibitor." In Encyclopedia of Systems Biology. Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4419-9863-7_1558.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Tyrosinase inhibitors"

1

Muthia, Karina, Fride Rindu Alami, Nyi Mekar Saptarini, and Jutti Levita. "Discovering Inhibitors of Tyrosinase Enzyme from Zingiberaceae for Depigmentation Agents." In 3rd International Conference on Computation for Science and Technology (ICCST-3). Atlantis Press, 2015. http://dx.doi.org/10.2991/iccst-15.2015.12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Boka, VI, A. Vontzalidou, K. Stathopoulou, et al. "A high-throughput multivariate statistics platform for the discovery of tyrosinase inhibitors." In 67th International Congress and Annual Meeting of the Society for Medicinal Plant and Natural Product Research (GA) in cooperation with the French Society of Pharmacognosy AFERP. © Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-3399822.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Casañola-Martín, Gerardo, Yovani Marrero-Ponce, Mahmud Khan, Arjumand Ather, Mukhlis Sultankhodzhaev, and Francisco Torrens. "In silico Discovery of Novel Tyrosinase Inhibitors using Atom Based Linear Indices." In The 10th International Electronic Conference on Synthetic Organic Chemistry. MDPI, 2006. http://dx.doi.org/10.3390/ecsoc-10-01451.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Luo, Huajun, Junzhi Wang, and Kun Zou. "QSAR Model of Hydroxy- or Methoxy-substituted Benzaldoximes and Benzaldehyde-o-alkyloximes as Tyrosinase Inhibitors." In 2010 WASE International Conference on Information Engineering (ICIE 2010). IEEE, 2010. http://dx.doi.org/10.1109/icie.2010.27.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Casañola-Martín, Gerardo, Yovani Marrero-Ponce, Mahmud Khan, et al. "The Dragon Method in the Computational Identification of Novel Tyrosinase Inhibitors. Results Supported by Experimental Assays." In The 10th International Electronic Conference on Synthetic Organic Chemistry. MDPI, 2006. http://dx.doi.org/10.3390/ecsoc-10-01452.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Mao, Hairong, Jiangang Xie, Qimeng Zhang, Xinyu Lu, and Shubai Li. "Relationships between Inhibition Constants, Types of Inhibition and IC50: Calculation and Comparison on IC50 of Two Model Tyrosinase Inhibitors." In 2010 4th International Conference on Bioinformatics and Biomedical Engineering (iCBBE). IEEE, 2010. http://dx.doi.org/10.1109/icbbe.2010.5515848.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Liu, Keshun, and Mike Woolman. "Developing an optimized method for measuring chymotrypsin inhibitor activity in protein products." In 2022 AOCS Annual Meeting & Expo. American Oil Chemists' Society (AOCS), 2022. http://dx.doi.org/10.21748/yucc6741.

Full text
Abstract:
Protease inhibitors of protein nature, such as trypsin inhibitors and chymotrypsin inhibitors, are rich in seeds of legume crops. Soybeans contain Kunitz inhibitor and Bowman-Birk inhibitor. The former mainly inhibits trypsin, while the latter inhibits both trypsin and chymotrypsin. Other legumes contain similar types. Historically, trypsin inhibitor activity in legume products has been of primary interest for measurement due to its antinutritional implication. However, Bowman-Birk inhibitor has been shown therapeutic. It is also more resistant to heat than Kunitz inhibitor. As increasing volu
APA, Harvard, Vancouver, ISO, and other styles
8

Sgorbini, Barbara, Francesca Capetti, Cecilia Cagliero, et al. "Citral Containing Essential Oils as Potential Tyrosinase Inhibitors: a bio-guided fractionation approach to investigate the additive and/or synergistic contribution of minor compounds." In GA – 69th Annual Meeting 2021, Virtual conference. Georg Thieme Verlag, 2021. http://dx.doi.org/10.1055/s-0041-1736961.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Kheraldine, Hadeel, Ishita Gupta, Farhan Cyprian, Semir Vranic, and Ala-Eddin Al Moustafa. "The Combination of Dasatinib and PD L1 inhibitor prevents the progression of epithelial mesenchymal transition and dramatically blocks cell invasion of HER2 positive breast cancer cells." In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2021. http://dx.doi.org/10.29117/quarfe.2021.0105.

Full text
Abstract:
Introduction: Both Dasatinib (DA), a tyrosine kinase inhibitor that is used for targeted cancer therapy, and programmed death-ligand 1 (PD-1/PD-L1) inhibitor that is an immune checkpoint therapy, play a vital role in the management of several types of solid tumors, including breast. Nevertheless, the combined outcome of DA and PD-1/PD-L1 inhibitors in human carcinomas has not been explored yet. Materials and methods: We herein compared the individual impact of DA and PD-1/PD-L1 inhibitors (BMS-202) with their combination on two human HER2-positive breast cancer cell lines, SKBR3 and ZR75. Resu
APA, Harvard, Vancouver, ISO, and other styles
10

Cvijetić, Ilija, Petar Ristivojević, Maja Krstić-Ristivojević та Dušanka Milojković-Opsenica. "EXPLORING THE POTENTIAL OF Α-ARBUTIN AS THE INHIBITOR OF NEURODEGENERATIVE DISORDERS". У 1st INTERNATIONAL Conference on Chemo and BioInformatics. Institute for Information Technologies, University of Kragujevac, 2021. http://dx.doi.org/10.46793/iccbi21.292c.

Full text
Abstract:
Tyrosinase is an enzyme involved in generation of dopamine-quinones, which has an important role in oxidative stress associated with the Parkinson’s disease. It is also a common molecular target for the design of novel anti-melanogenic agents. The inhibition of tyrosinase might be responsible for the experimentally observed intracellular antioxidant activity of α-arbutin. Moreover, intrinsic radical scavenging capacity of α-arbutin should also be considered. The binding mode of α-arbutin into the active site of Bacillus megaterium tyrosinase is predicted using AutoDock Vina 1.1. To map the the
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Tyrosinase inhibitors"

1

Zheng, Jiaxi, and Haihua Yang. Clinical Benefits of Immune Checkpoint Inhibitors and Predictive Value of Tumor Mutation Burden in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.1.0008.

Full text
Abstract:
Review question / Objective: Is immunotherapy associated with beneficial clinical outcomes for hepatocellular carcinoma (HCC) and how can combination immunotherapy be deployed to produce the best benefit? Is tumor mutation burden (TMB) a predictive biomarker for immune‐checkpoint inhibitors? Condition being studied: To this date, about 50 single-arm clinical trials and several randomized control trials (RCTs) presented final or interim results of investigations on the efficacy of PD-1/PD-L1 inhibitors for advanced HCC. In the CheckMate 459, IMbrave 050, and ORIENT-32, immunotherapies were foun
APA, Harvard, Vancouver, ISO, and other styles
2

Miller, Tod. Peptide-Bassed Inhibitors of Neu Tyrosine Kinase. Defense Technical Information Center, 1999. http://dx.doi.org/10.21236/ada375133.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Miller, W. T. Peptide-Based Inhibitors of Neu Tyrosine Kinase. Defense Technical Information Center, 2000. http://dx.doi.org/10.21236/ada392289.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Tinker, Anna V., Neesha C. Dhani, Prafull Ghatage, et al. Immune Checkpoint Inhibitors in Pretreated Metastatic Endometrial Cancer. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2023. http://dx.doi.org/10.37766/inplasy2023.1.0038.

Full text
Abstract:
Review question / Objective: Efficacy and safety of immune checkpoint inhibitors alone or in combination with tyrosine kinase inhibitors in patients with pretreated advanced, persistent, or recurrent metastatic endometrial cancer. Condition being studied: Advanced, persistent, or recurrent metastatic endometrial cancer. Study designs to be included: Non-randomized studies of monotherapy in populations selected for relevant biomarkers such as MMR, microsatellite stability, and PD-L1 expression status and randomized trials of ICI combinations in unselected patients.
APA, Harvard, Vancouver, ISO, and other styles
5

Rosen, Neal. Development of Targeted Ansamycins as Novel Antiestrogens and Tyrosine Kinase Inhibitors. Defense Technical Information Center, 1998. http://dx.doi.org/10.21236/ada369205.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Rosen, Neal. Development of Targeted Ansamycins as Noval Antiestrogens and Tyrosine Kinase Inhibitors. Defense Technical Information Center, 2000. http://dx.doi.org/10.21236/ada413599.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Eom, Tae-Kil, Ekyune Kim, and Ju-Sung Kim. Inhibitory Effects of 6,6′‑bieckol from Ishige okamurae on Tyrosinase Activity and Melanin Synthesis in Mouse B16F10 Melanoma Cells. "Prof. Marin Drinov" Publishing House of Bulgarian Academy of Sciences, 2019. http://dx.doi.org/10.7546/crabs.2019.09.18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Kockel, Lutz. Isolation and Analysis of Human Kekkon-Like Molecules, a Family of Potential Inhibitors of ErbB Receptor Tyrosine Kinases. Defense Technical Information Center, 2005. http://dx.doi.org/10.21236/ada443751.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Edelman, Arthur. Study of Inhibitors of Neu and Related Tyrosine-Specific Protein Kinases: Implications for the Treatment of Breast Cancer. Defense Technical Information Center, 1998. http://dx.doi.org/10.21236/ada360940.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Edelman, Arthur. Study of Inhibitors of Neu and Related Tyrosine-Specific Protein Kinases: Implications for the Treatment of Breast Cancer. Defense Technical Information Center, 1997. http://dx.doi.org/10.21236/ada338938.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!